AAAAAA
Results:
1-7
|
Results: 7
Authors:
Furlong, WJ
Feeny, DH
Torrance, GW
Barr, RD
Citation: Wj. Furlong et al., The Health Utilities Index (HUI (R)) system for assessing health-related quality of life in clinical studies, ANN MED, 33(5), 2001, pp. 375-384
Authors:
Torrance, GW
Feeny, D
Furlong, W
Citation: Gw. Torrance et al., Visual analog scales: Do they have a role in the measurement of preferences for health states?, MED DECIS M, 21(4), 2001, pp. 329-334
Authors:
Stalmeier, PFM
Goldstein, MK
Holmes, AM
Lenert, L
Miyamoto, J
Stiggelbout, AM
Torrance, GW
Tsevat, J
Citation: Pfm. Stalmeier et al., What should be reported in a methods section on utility assessment?, MED DECIS M, 21(3), 2001, pp. 200-207
Authors:
Grima, DT
Torrance, GW
Francis, G
Rice, G
Rosner, AJ
Lafortune, L
Citation: Dt. Grima et al., Cost and health related quality of life consequences of multiple sclerosis, MULT SCLER, 6(2), 2000, pp. 91-98
Authors:
Bennett, KJ
Torrance, GW
Boyle, MH
Guscott, R
Citation: Kj. Bennett et al., Cost-utility analysis in depression: The McSad utility measure for depression health states, PSYCH SERV, 51(9), 2000, pp. 1171-1176
Authors:
Bennett, KJ
Torrance, GW
Boyle, MH
Guscott, R
Moran, LA
Citation: Kj. Bennett et al., Development and testing of a utility measure for major, unipolar depression (McSad), QUAL LIFE R, 9(1), 2000, pp. 109-120
Authors:
Glennie, JL
Torrance, GW
Baladi, JF
Berka, C
Hubbard, E
Menon, D
Otten, N
Riviere, M
Citation: Jl. Glennie et al., The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals, PHARMACOECO, 15(5), 1999, pp. 459-468
Risultati:
1-7
|